Hilario A, Sepulveda J M, Perez-Nuñez A, Salvador E, Millan J M, Hernandez-Lain A, Rodriguez-Gonzalez V, Lagares A, Ramos A
From the Departments of Radiology (A.H., A.R., E.S., J.M.M.)
Medical Oncology (J.M.S.).
AJNR Am J Neuroradiol. 2014 Jun;35(6):1096-102. doi: 10.3174/ajnr.A3837. Epub 2014 Jan 23.
Diffuse gliomas are classified as grades II-IV on the basis of histologic features, with prognosis determined mainly by clinical factors and histologic grade supported by molecular markers. Our aim was to evaluate, in patients with diffuse gliomas, the relationship of relative CBV and ADC values to overall survival. In addition, we also propose a prognostic model based on preoperative MR imaging findings that predicts survival independent of histopathology.
We conducted a retrospective analysis of the preoperative diffusion and perfusion MR imaging in 126 histologically confirmed diffuse gliomas. Median relative CBV and ADC values were selected for quantitative analysis. Survival univariate analysis was made by constructing survival curves by using the Kaplan-Meier method and comparing subgroups by log-rank probability tests. A Cox regression model was made for multivariate analysis.
The study included 126 diffuse gliomas (median follow-up of 14.5 months). ADC and relative CBV values had a significant influence on overall survival. Median overall survival for patients with ADC < 0.799 × 10(-3) mm(2)/s was <1 year. Multivariate analysis revealed that patient age, relative CBV, and ADC values were associated with survival independent of pathology. The preoperative model provides greater ability to predict survival than that obtained by histologic grade alone.
ADC values had a better correlation with overall survival than relative CBV values. A preoperative prognostic model based on patient age, relative CBV, and ADC values predicted overall survival of patients with diffuse gliomas independent of pathology. This preoperative model provides a more accurate predictor of survival than histologic grade alone.
弥漫性胶质瘤根据组织学特征分为II-IV级,其预后主要由临床因素决定,分子标志物辅助组织学分级。我们的目的是评估弥漫性胶质瘤患者的相对脑血容量(CBV)和表观扩散系数(ADC)值与总生存期的关系。此外,我们还基于术前磁共振成像(MR)结果提出了一种独立于组织病理学预测生存期的预后模型。
我们对126例经组织学证实的弥漫性胶质瘤患者的术前扩散和灌注MR成像进行了回顾性分析。选择CBV和ADC值的中位数进行定量分析。采用Kaplan-Meier法构建生存曲线,并通过对数秩概率检验比较亚组,进行生存单因素分析。采用Cox回归模型进行多因素分析。
该研究纳入126例弥漫性胶质瘤患者(中位随访时间为14.5个月)。ADC值和相对CBV值对总生存期有显著影响。ADC<0.799×10(-3)mm(2)/s的患者中位总生存期<1年。多因素分析显示,患者年龄、相对CBV值和ADC值与生存期相关,且独立于病理情况。术前模型预测生存期的能力优于单纯依靠组织学分级。
ADC值与总生存期的相关性优于相对CBV值。基于患者年龄、相对CBV值和ADC值的术前预后模型可独立于病理情况预测弥漫性胶质瘤患者的总生存期。该术前模型比单纯组织学分级能更准确地预测生存期。